Htr3atm1c(EUCOMM)Wtsi
Targeted Allele Detail
|
Symbol: |
Htr3atm1c(EUCOMM)Wtsi |
Name: |
5-hydroxytryptamine (serotonin) receptor 3A; targeted mutation 1c, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:6406441 |
Gene: |
Htr3a Location: Chr9:48810513-48822399 bp, - strand Genetic Position: Chr9, 26.53 cM
|
Alliance: |
Htr3atm1c(EUCOMM)Wtsi page
|
IMPC: |
Htr3a gene page |
|
Mutant Cell Line: |
EPD0820_5_A08 |
Germline Transmission: |
Earliest citation of germline transmission:
J:82809
|
Parent Cell Line: |
JM8A3.N1 (ES Cell)
|
Strain of Origin: |
C57BL/6N-Atm1Brd
|
Project Collection: |
EUCOMM
|
|
Allele Type: |
|
Targeted (Conditional ready, No functional change) |
Mutation: |
|
Insertion
Vector: L1L2_Bact_P
|
|
|
Mutation details: The L1L2_Bact_P cassette was inserted at position 48815122 of Chromosome 9 upstream of the critical exon(s) (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. A third loxP site is inserted downstream of the targeted exon(s) at position 48816445. The critical exon(s) is/are thus flanked by loxP sites. A "conditional ready" (floxed) allele was created by flp recombinase expression in mice carrying this allele. Subsequent cre expression results in a knockout mouse. Further information on targeting strategies used for this and other IKMC alleles can be found at http://www.informatics.jax.org/mgihome/nomen/IKMC_schematics.shtml
(J:82809)
|
|
|
|
Original: |
J:82809 European Mouse Mutant Archive, Information obtained from the European Mouse Mutant Archive (EMMA). Unpublished. 2003-2013; |
All: |
1 reference(s) |
|